Blood Advances (Apr 2018)

Should all patients with Hodgkin lymphoma who relapse after autologous SCT be considered for allogeneic SCT?

Karl S. Peggs

Affiliations

Karl S. Peggs: Karl S. Peggs, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley St, London WC1E 6BT, United Kingdom;; University College London Cancer Institute, London, United Kingdom

Journal volume & issue: Vol. 2, no. 7
pp. 817 – 820

Abstract

No abstracts available.

Published in Blood Advances

ISSN: 2473-9529 (Print); 2473-9537 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine
Website: https://ashpublications.org/bloodadvances

About the journal